coming back to life ?

RNS Number : 6942W
Plant Health Care PLC
13 June 2008

TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES




1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):




PLANT HEALTH CARE plc




2. Reason for the notification (please state Yes/No): ( )

An acquisition or disposal of voting rights: (YES)

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( )

An event changing the breakdown of voting rights: ( )

Other (please specify): ()




3. Full name of person(s) subject to the notification obligation (iii):




Generation Investment Management LLP




4. Full name of shareholder(s) (if different from 3.) (iv):




Generation IM Climate Solutions Fund, L.P.




5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v):

10/06/2008

6. Date on which issuer notified:




12/06/2008




7. Threshold(s) that is/are crossed or reached:



5%




8. Notified details:




A: Voting rights attached to shares




Class/type of shares if possible using the ISIN CODE
Situation previous to the Triggering transaction (vi)



Number of shares
Number of voting Rights (viii)

GB00B01JC540
1,640,000
1,640,000





Resulting situation after the triggering transaction (vii)

Class/type of shares if possible using the ISIN CODE
Number of shares

Number of voting rights (ix)

% of voting rights






Direct (x)
Indirect (xi)
Direct
Indirect

GB00B01JC540
2,355,000


2,355,000


5.256%





B: Financial Instruments




Resulting situation after the triggering transaction (xii)




Type of financial instrument




Expiration Date (xiii)






Exercise/Conversion Period/Date (xiv)





Number of voting rights that may be acquired if the instrument is exercised/ converted.



% of voting rights



















Total (A+B)




Number of voting rights



% of voting rights

2,355,000
5.256%





9. Chain of controlled undertakings through which the voting rights and/or the financial instruments
are effectively held, if applicable (xv):




Generation Investment Management LLP - Indirect:

Generation IM Climate Solution Fund, L.P. : 2,355,000 5.256% = Total Position




Proxy Voting:




10. Name of the proxy holder:




N/A




11. Number of voting rights proxy holder will cease to hold:




N/A




12. Date on which proxy holder will cease to hold voting rights:




N/A




13. Additional information:




Notification is based on using the total voting rights figure of 44,802,000.




14. Contact name:




(i) Andrew Wood FCIS, Company Secretary




(II) Tim Redfern, Evolution Securities Limited




(iii) Jeremy Carey, Tavistock Communications




15. Contact telephone number:




+44 (0)20 8866 5702

+44 (0)20 7071 4300

+44 (0)20 7920 3150




Annex to Notification Of Major Interests In Shares (xvi)




A: Identity of the person or legal entity subject to the notification obligation




Full name (including legal form for legal entities):




Generation Investment Management LLP




Contact address (registered office for legal entities):




4 Cork Street
London
W1S 3LG




Phone number:




020 7534 4700




Other useful information (at least legal representative for legal persons):




Peter Harris




B: Identity of the notifier, if applicable (xvii)




Full name:







Contact address:





Phone number:




Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)




END

13 June 2008

4 July 2008










Plant Health Care plc

('Plant Health Care' or 'the Company')




More Potential Benefits Indicated for Plant Health Care's Myconate




VA Mycorrhizal fungi produce glomalin,

a soil constituent that locks up soil carbon




Plant Health Care (AIM: PHC.L), a leading provider of natural products for plants and soil announces that the United States Department of Agriculture, Agricultural Research Service (USDA-ARS) has found that a soil constituent known as glomalin and produced by beneficial vesicular arbuscular mycorrhizal fungi (VAM) locks up soil carbon. VAM development and colonisation of plant roots is known to be stimulated by Plant Health Care's Myconate. The findings on glomalin come from research conducted by Kristine Nichols, a microbiologist at the USDA-ARS in Mandan, North Dakota. The report is based in part on carbon-dating studies of glomalin.




Dr. Greg Lewis, Vice President, Corporate Development at Plant Health Care says: 'VAM fungi act as a secondary plant root system, increasing a crop's ability to access and use available moisture and nutrients. By taking advantage of these known benefits of VA mycorrhizal fungi, growers can now not only improve the performance of their crops and enhance soil fertility, they may also be able to contribute to the long-term reduction of carbon dioxide from the atmosphere. Our Myconate product has been shown to encourage the development of VAM fungi in a growing number of agricultural crops.'




Glomalin is a sticky substance secreted by threadlike fungal structures called hyphae that funnel nutrients and water to plant roots. It is named after the Glomerales, the group of fungi to which some VAM fungi belong. So far, VAM fungi appear to be the only producers of glomalin.




Greg Lewis added, 'Plant Health Care has known for some time the benefits of mycorrhizal fungi, including the Glomerales, to plants and the soil and it is most encouraging to see the ARS document that these same organisms can contribute to carbon storage in soils. The ARS suggests that glomalin can keep carbon from decomposing for up to100 years. This is significant for the reduction of carbon dioxide in the atmosphere.'




Plant Health Care offers the product Myconate, which stimulates the colonization of plants by native VAM fungi already present in the soil. Myconate offers the potential to increase yields and tests are underway to determine if the expanded root mass observed on Myconate-treated crops will allow for a reduction in irrigation and nutritional inputs as well. Preliminary on-farm trials have shown very promising results in row crops, cereals and several vegetable crops such as carrots, potatoes and celery. Other potential crops being studied include perennials like fruits and vines and more vegetable crops like peppers, tomatoes and cucurbits. Myconate can be applied to a seed or watered into the ground very easily via irrigation systems. Myconate's net effect is to stimulate the colonization of native VAM soil fungi on plant roots, improving a crop's ability to access moisture and nutrients.




- Ends -




For Further Information:




John Brady
Evolution Securities Limited
Tavistock Communications

Chief Executive
Tim Worlledge/Grant Schaffer
Jeremy Carey/Simon Compton

Tel: 001 603 525 3702
Tel: 020 7071 4300
Tel: 020 7920 3150








Myconate, ProAct, N-Hibit PHC, and the Plant Health Care, Inc. logo are trademarks of Plant Health Care, Inc.




Notes to editors:

'Glomalin is Key to Locking up Soil Carbon' By Don Comis was published on June 17, 2008 on the USDA-ARS website at www.ars.usda.gov/is/pr/2008/080617.htm?pf=1







About Plant Health Care




Plant Health Care plc is a leading provider of natural products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, PHC currently has approximately 70 employees and has operations in the United States, Mexico, the United Kingdom, Spain, and the Netherlands. The Company listed on the AIM market of the London Stock Exchange in July 2004. Ticker symbol is PHC.




PHC's products are aimed at the landscape, agriculture and land reclamation industries and are environmentally beneficial. Through the commercialization of these products, PHC is capitalizing on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com.





This information is provided by RNS
The company news service from the London Stock Exchange

You cant keep a good share down!

RNS Number : 0328E
Plant Health Care PLC
23 September 2008






23 September 2008










Plant Health Care plc

('Plant Health Care' or 'the Company')







IMPRESSIVE YIELD GAINS FROM PRETECT TRIALS




Plant Health Care (AIM: PHC.L), a leading provider of natural products to the agriculture and landscape industries, announces that independent trials of PreTect, the Harpin based foliar fertiliser, have resulted in impressive yield gains across a variety of crops.




The trials were undertaken in Spain, by SICOP a Spanish government approved trials agency, over the past 12 months as part of government required efficacy tests. The results of tests on olives, tomatoes, strawberries and lettuce showed significant improvements across a number of key metrics. These trial results were the final requirement for full registration of Harpin across all crops in Spain and will enable PHC to make shelf life and vigor claims in that market.




When a small amount of PreTect was applied to tomatoes, it led to an increase in flowering and fruiting maturity, and an increase of 2.6% in yield and over 20% in the key category of firmness. The increase in firmness is the parameter that dictates the shelf-life of tomatoes and therefore helps reduce wastage and increase farmers' profits. There were over 3.6 million tonnes of tomatoes produced in Spain in 2007.




Tests on olives showed an increase of 3.3% in yield and 5.4% in fruit size and most importantly a significant increase in oil content. There are currently around six million acres of olives harvested in Spain per year.




Results on lettuce indicated increases in yield of 4.3% per lettuce head and strawberries showed average increases of 5.8%.




John Brady, CEO of Plant Health Care commented, 'These results further validate the efficacy of PreTect following the announcement in June 2008 of its successful trials across a variety of soft fruits.




'A wealth of data has shown that PreTect offers an effective method of increasing the yield and shelf-life of a variety of crops. These results help to further position Plant Health Care as a key player in the worldwide effort to increase food production and quality while also reducing synthetic chemical use.'




- ends -




For Further Information:




John Brady
Evolution Securities Limited
Tavistock Communications

Chief Executive
Tim Worlledge/Tim Redfern
Jeremy Carey/Simon Compton

Tel: 001 603 525 3702
Tel: 020 7071 4300
Tel: 020 7920 3150

For release on RNS Reach:

25 September 2008










Plant Health Care plc

('Plant Health Care' or 'the Company')




FIRST MAJOR ORDER FOR NATURAL PRODUCTS SUPPLY AGREEMENT




Following the announcement of a multi-year supply agreement on 8 September 2008 with The Scotts Company ('Scotts'), Plant Health Care (AIM: PHC.L), a leading provider of natural products to the agriculture and landscape industries, announces its first significant order for the supply of PHC's Natural Plant Food, for immediate delivery.




Scotts are the global leader in the consumer lawn and garden industry and under the terms of the agreement, Plant Health Care will supply Scotts with natural products for inclusion in their line of lawn and garden products for the retail market.




John Brady, CEO of Plant Health Care commented, 'This agreement allows us to participate in the retail markets with the global leader and is an important step towards our stated goal of becoming one of the world's leading developers and suppliers of natural products for plant health.









- ends

This lot only deal with good news!

RNS Number : 9078E
Plant Health Care PLC
02 October 2008




2 October 2008






Plant Health Care plc

('Plant Health Care' or 'the Company')




IMPRESSIVE YIELD GAINS FROM SOUTH AFRICAN HARPIN TRIALS




Plant Health Care (AIM: PHC.L), a leading provider of natural products to the agriculture and landscape industries, announces that independent trials of a Harpin based treatment, on commercial potato production in South Africa, have resulted in significant yield gains compared to conventional chemical treatments.




The comparison trials were undertaken in South Africa, by Bayagro, an important distributor to the potato industry, and presented to the Potato Seed Council of South Africa to show the efficacy of 20 combination chemical and natural potato treatments. This trial was conducted to establish a new 'best practice' for potato growing in South Africa.




The results showed that a Harpin based product, when used in conjunction with a standard treatment, yielded 8.1% more than all other treatments, including the current industry standard. These results have established Harpin as the new standard treatment for potato production in South Africa.




As a result of these successful trials Jason Holohan, Managing Director of UK/Spain, was invited as a guest speaker to address the recent annual South African Seed Potato Growers Forum. This forum represents growers from the potato industry in South Africa which harvests over 60,000 hectares.




John Brady, CEO of Plant Health Care commented, 'South Africa represents a new and exciting market for PHC. As a result of Jason's initiative in this market and the resultant successful trials we have received significant orders for the remainder of the 2008 season as well as for 2009. We now have a strong distributor in this market and look forward to initiating sales into a variety of crops with both Harpin and Myconate.'




- ends -

RNS Number : 1880K
Plant Health Care PLC
16 December 2008



16 December 2008







Plant Health Care plc

('Plant Health Care' or 'the Company')




PLANT HEALTH CARE AND MONSANTO SIGN FINAL AGREEMENT FOR THE COMMERCIALISATION OF HARPIN TECHNOLOGY







Plant Health Care Inc, a wholly owned subsidiary of Plant Health Care plc (AIM: PHC), and Monsanto Company (NYSE: MON) have entered into an agreement for the commercialisation of harpin-based technology as a seed treatment in Monsanto's major row crops and vegetables. The harpin technology offers farmers in-season benefits, including the suppression of pests like nematodes and yield-inhibiting diseases, as well as additive plant health benefits. The technology is a specific type of protein that activates a plant's intrinsic ability to protect itself and enhances growth. Over the past year Monsanto has evaluated the technology and will proceed to continue commercial development of harpin seed treatment as part of its global seed treatment platform.




Under the long-term agreement, Plant Health Care will license to Monsanto the exclusive rights to commercialise harpin seed treatment technology in corn, soybeans, cotton, canola and selected vegetables. In return, Plant Health Care will receive the milestone payment agreed under the Evaluation and Development Agreement announced in December 2007, plus ongoing royalties based on the total volume of Harpin seed treatment. As part of the agreement Monsanto will issue an order of product to be delivered by the end of this year. Financial terms were not disclosed, although Plant Health Care believes the agreement will make a material contribution to the company's future revenue and profits.




John Brady, CEO of Plant Health Care commented, 'This agreement, and the order for product which is 12 months earlier than anticipated, is transformational for Plant Health Care and is fundamental proof of our model for commercialising our technology portfolio in partnership with major industry players. Monsanto is an excellent partner, and its seed brands hold leading positions around the world.




He added: 'Plant Health Care's range of technologies, which includes harpin, are ideally placed to maximize yield benefits in today's environment of rising food prices and increased global demand for high-protein diets.'




Randy Barker, Monsanto's seed treatment strategy lead, said, 'We are pleased to be working with Plant Health Care to deliver technology that can provide plant health benefits. Seed treatments are a natural complement to our seed strategy and yield-enhancing technology, which enhance the profitability for our farmer customers.'




Monsanto seeds treated with Harpin may be available to farmers as part of its Acceleron brand seed treatment as early as 2010. Monsanto's Acceleron brand will represent a wide range of evolving seed-performance technologies dedicated to improving plant health.




For further information, please contact:




Plant Health Care plc
Monsanto Company

John Brady, Chief Executive Officer
Danielle Jany

Tel: +1-603-525-3702

Tel: +44-20-7920-3150 (16-19 December)
Tel: +1-314-694-2478

jabrady@planthealthcare.com
danielle.c.jany@monsanto.com




Evolution Securities



Tavistock Communications

Tim Worlledge / Tim Redfern
Jeremy Carey/Matt Ridsdale

Tel: +44-20-7071-4300
Tel: +44-20-7920-3150

tim.worlledge@evosecuties.com/

tim.redfern@evosecuties.com
jcarey@tavistock.co.uk / mridsdale@tavistock.co.uk

STOCKS NEWS Reuters Results diary

Europe Real-time Equity News

UK Stocks on the move

UK smallcaps



08:50GMT 16Dec2008-Plant Health Care rises on Monsanto deal

-----------------------------------------------------------

Shares in Plant Health Care rise 17.5 percent to 218 pence as the group reaches an agreement to license its harpin seed treatment to U.S. biotech company Monsanto Co for row crops and vegetables.

'Today's confirmation that Monsanto will deploy harpin in its seed-coating product for soybeans, corn, cotton and certain vegetables gives investors the long-term visibility they have been waiting for,' says Philip Sparks at Evolution Securities.

He estimates the deal could generate about 15 million pounds a year of earnings in the medium term, and the U.S. sales of harpin as a seed coating could be worth 450 pence per share on their own.

For more, click on

Reuters messaging rm://paul.sandle.reuters.com@reuters.net



08:47GMT 16Dec2008-Kesa falls on poor H1 results, downgrades

------------------------------------------------------------



Plant Health Care plc surges 16 percent after announcing its wholly owned subsidiary, Plant Health Care Inc, and Monsanto Co have entered into an agreement for the commercialisation of harpin-based technology as a seed treatment in Monsanto's major row crops and vegetables.

New article should please holders!

Click HERE

bid rumour

Seen/heard where, and who's in the frame?